Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,662.00    68.00 (1.48%)
Bid:
4,650.00
Ask:
4,654.00
Spread: 4.00 (0.086%)
Market Cap: £16.99b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Syndicated Multi-Currency RCF

25 Jun 2015 14:51

RNS Number : 2639R
Coca-Cola HBC AG
25 June 2015
 



 

FOR IMMEDIATE RELEASE

 

Coca-Cola HBC AG and Coca-Cola HBC Finance B.V.

announce renewal of Syndicated Multi-Currency Revolving Credit Facility

25 June 2015 - Coca-Cola HBC AG ("Coca-Cola HBC" and, together with its subsidiaries, the "Group") and Coca-Cola HBC Finance B.V. announce the replacement of the Group's existing EUR 500,000,000 Syndicated Multi-Currency Revolving Credit Facility (the "Previous Facility"), which was set to expire in May 2016, with a new EUR 500,000,000 Syndicated Multi-Currency Revolving Credit Facility having a term of five years with a one-year extension option (the "Facility"). The Facility can be used for general corporate purposes. The Previous Facility has been cancelled.

Coca-Cola HBC Finance B.V. is the borrower under the Facility (the "Borrower"). The obligations of the Borrower under the Facility are guaranteed by both Coca-Cola HBC and Coca-Cola HBC Holdings B.V..

Deutsche Bank Luxembourg and ING acted as Co-ordinators for the Facility. The Bookrunner Mandated Lead Arrangers are BNP Paribas, Citi, Credit Suisse AG, Deutsche Bank Luxembourg, ING, Intesa Sanpaolo S.p.A., Société Générale and UniCredit Bank AG, and the Lead Arranger is Raiffeisen Bank International AG.

 

 

 

 

Enquiries

Coca‑Cola HBC Group

Basak Kotler

Investor Relations Director

 

Tel: +41 41 726 0143

 basak.kotler@cchellenic.com

 

Eri Tziveli

Investor Relations Manager

Tel: +30 210 618 3133

 eri.tziveli@cchellenic.com

 

Nikos Efstathopoulos

Investor Relations Manager

Tel: +30 210 618 3260

 nikos.efstathopoulos@cchellenic.com

 

International media contact:

StockWell Communications

Rob Morgan

Ben Ullmann

Anushka Mathew

Tel: +44 20 7240 2486

 robert.morgan@stockwellgroup.com

 ben.ullmann@stockwellgroup.com

 anushka.mathew@stockwellgroup.com

 

Greek media contact:

V+O Communications

Argyro Oikonomou

Tel: +30 211 7501219

 ao@vando.gr

 

 

About Coca‑Cola HBC

Coca-Cola HBC is the second-largest bottler of the brands of The Coca-Cola Company in terms of volume with sales of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 590 million people. Coca-Cola HBC offers a diverse range of non-alcoholic ready to drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). Coca-Cola HBC is included in the Dow Jones Sustainability and FTSE4Good Indexes. For more information, please visit http://www.coca-colahellenic.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCXELFLEQFZBBK
Date   Source Headline
21st Jun 20245:11 pmRNSTransaction in Own Shares
20th Jun 20245:45 pmRNSTransaction in Own Shares
19th Jun 20245:14 pmRNSTransaction in Own Shares
18th Jun 20245:09 pmRNSTransaction in Own Shares
18th Jun 20244:23 pmRNSDirector/PDMR Shareholding
17th Jun 20245:20 pmRNSTransaction in Own Shares
14th Jun 20245:11 pmRNSTransaction in Own Shares
14th Jun 20247:09 amRNSTransaction in Own Shares
11th Jun 20245:41 pmRNSTransaction in Own Shares
10th Jun 20245:25 pmRNSTransaction in Own Shares
5th Jun 20245:32 pmRNSTransaction in Own Shares
4th Jun 20245:28 pmRNSTransaction in Own Shares
3rd Jun 20245:19 pmRNSTransaction in Own Shares
3rd Jun 20244:11 pmRNSIssue of Equity and total voting rights
31st May 20245:25 pmRNSTransaction in Own Shares
30th May 20245:36 pmRNSTransaction in Own Shares
29th May 20243:25 pmRNSDirector/PDMR Shareholding
29th May 20243:19 pmRNSDirector/PDMR Shareholding
28th May 202410:07 amRNSDirector/PDMR Shareholding
28th May 202410:04 amRNSDirector/PDMR Shareholding
22nd May 20245:43 pmRNSDirector/PDMR Shareholding
21st May 20246:01 pmRNSComposition of the Board Committees
21st May 20245:55 pmRNSResult of AGM
20th May 20244:44 pmRNSDirector/PDMR Shareholding
15th May 20244:19 pmRNSDirector/PDMR Shareholding
13th May 202411:30 amRNSDirector/PDMR Shareholding
8th May 20245:50 pmRNSTransaction in Own Shares
7th May 20245:29 pmRNSTransaction in Own Shares
3rd May 20245:25 pmRNSTransaction in Own Shares
3rd May 202412:46 pmRNSDirector/PDMR Shareholding
3rd May 202412:38 pmRNSDirector/PDMR Shareholding
2nd May 20245:41 pmRNSTransaction in Own Shares
2nd May 202412:40 pmRNSAthens Exchange trading date of ordinary shares
1st May 20245:47 pmRNSTransaction in Own Shares
1st May 202410:09 amRNSBlock listing Interim Review
1st May 20249:10 amRNSIssue of equity and total voting rights
30th Apr 20247:00 amRNSStrong start; reiterating 2024 guidance
19th Apr 20249:20 amRNSNotice of AGM
18th Apr 20244:21 pmRNSDirector/PDMR Shareholding
5th Apr 20242:17 pmRNSNotice of Results
2nd Apr 202411:12 amRNSIssue of equity and total voting rights
28th Mar 20245:55 pmRNSDirector/PDMR Shareholding
28th Mar 20245:47 pmRNSDirector/PDMR Shareholding
28th Mar 20245:42 pmRNSDirector/PDMR Shareholding
28th Mar 20245:26 pmRNSTransaction in Own Shares
27th Mar 20245:23 pmRNSTransaction in Own Shares
26th Mar 20245:05 pmRNSTransaction in Own Shares
26th Mar 20249:09 amRNSDirector/PDMR Shareholding
25th Mar 20245:10 pmRNSTransaction in Own Shares
22nd Mar 20245:27 pmRNSTransaction in Own Shares - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.